Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
2 studies found for:    "fish-eye disease" OR "LCATA deficiency" OR "alpha-LCAT deficiency" OR "alpha-lecithin:cholesterol acyltransferase deficiency" OR "dyslipoproteinemic corneal dystrophy"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"fish-eye disease" OR "LCATA deficiency" OR "alpha-LCAT deficiency" OR "alpha-lecithin:cholesterol acyltransferase deficiency" OR "dyslipoproteinemic corneal dystrophy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Mendelian Reverse Cholesterol Transport Study
Conditions: Cholesterol, HDL;   Lipid Metabolism, Inborn Errors;   Tangier Disease;   LCAT Deficiency;   Cholesteryl Ester Transfer Protein (CETP) Deficiency
Intervention: Drug: 3H-cholesterol bound to albumin
2 Completed Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
Conditions: Coronary Artery Disease;   Atherosclerosis
Intervention: Drug: ACP-501
To Top

† Indicates status has not been verified in more than two years